R A Hubner

Summary

Affiliation: Institute of Cancer Research
Country: UK

Publications

  1. ncbi Molecular advances in medullary thyroid cancer diagnostics
    Richard A Hubner
    Institute of Cancer Research, Cancer Genetics, 15 Cotswold Road, Sutton, SM2 5NG, United Kingdom
    Clin Chim Acta 370:2-8. 2006
  2. ncbi Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom
    Clin Cancer Res 14:2303-9. 2008
  3. ncbi Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma
    R A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, UK
    Br J Cancer 97:1449-56. 2007
  4. ncbi Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton SM2 5NG, United Kingdom
    Int J Cancer 121:2001-4. 2007
  5. ncbi Should folic acid fortification be mandatory? No
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, Sutton SM2 5NG
    BMJ 334:1253. 2007
  6. ncbi MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Rsearch, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Hum Mol Genet 16:1072-7. 2007
  7. ncbi MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom
    Int J Cancer 120:1027-35. 2007
  8. ncbi Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, 15 Cotswold Road, Sutton SM2 5NG, United Kingdom
    Cancer Epidemiol Biomarkers Prev 15:1607-13. 2006
  9. ncbi Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, Sutton SM2 5NG, United Kingdom
    Int J Cancer 123:586-93. 2008
  10. ncbi Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom and Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, University of Nottingham, Nottingham, United Kingdom
    Clin Cancer Res 12:6585-9. 2006

Detail Information

Publications11

  1. ncbi Molecular advances in medullary thyroid cancer diagnostics
    Richard A Hubner
    Institute of Cancer Research, Cancer Genetics, 15 Cotswold Road, Sutton, SM2 5NG, United Kingdom
    Clin Chim Acta 370:2-8. 2006
    ..Mutation analysis of RET in individuals with MEN2 has identified a number of different mutations, and correlation with cancer biology and clinical outcome has led to tailoring of management according to the mutation detected...
  2. ncbi Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom
    Clin Cancer Res 14:2303-9. 2008
    ..We investigated the influence of ODC G316A on the chemopreventive activity of aspirin in colorectal adenoma (CRA) recurrence...
  3. ncbi Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma
    R A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton SM2 5NG, UK
    Br J Cancer 97:1449-56. 2007
    ....
  4. ncbi Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton SM2 5NG, United Kingdom
    Int J Cancer 121:2001-4. 2007
    ..These data indicate that these polymorphisms are unlikely to influence CRA recurrence and cannot be used to identify individuals who derive benefit from aspirin intervention...
  5. ncbi Should folic acid fortification be mandatory? No
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, Sutton SM2 5NG
    BMJ 334:1253. 2007
  6. ncbi MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Rsearch, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Hum Mol Genet 16:1072-7. 2007
    ..Stratification by MSI status should aid future studies investigating the complex relationships between genotype, environmental factors and CRC risk...
  7. ncbi MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom
    Int J Cancer 120:1027-35. 2007
    ....
  8. ncbi Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, 15 Cotswold Road, Sutton SM2 5NG, United Kingdom
    Cancer Epidemiol Biomarkers Prev 15:1607-13. 2006
    ..These findings provide additional support for the hypothesis that germ line variants in folate metabolism genes influence the development of colorectal adenomas...
  9. ncbi Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, Sutton SM2 5NG, United Kingdom
    Int J Cancer 123:586-93. 2008
    ..02). These findings indicate dairy products, and in particular milk, have chemopreventive activity against CRA recurrence...
  10. ncbi Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom and Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, University of Nottingham, Nottingham, United Kingdom
    Clin Cancer Res 12:6585-9. 2006
    ..We aimed to further investigate the effect of these genetic variants on the development of colorectal neoplasia...
  11. ncbi Re: MLH1 93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer
    Richard A Hubner
    J Natl Cancer Inst 99:1490; author reply 1490-1. 2007